A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations

Name: A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations
Published: 2012
License: Public Domain

Arog Pharmaceuticals, Inc. · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

acute myeloid

acute myeloid leukemia with flt3 activating mutations that has relapsed or been refractory after one or more prior therapies, flt3, crenolanib, acute, myeloid, aml, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients With FLT3 Activating Mutations

Related documents